SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.1130
-0.0010 (-0.88%)
At close: Apr 1, 2026
SoftOx Solutions AS Revenue
In the year 2025, SoftOx Solutions AS had annual revenue of 15.58M NOK with 96.92% growth. SoftOx Solutions AS had revenue of 3.61M in the quarter ending December 31, 2025, with 123.16% growth.
Revenue
15.58M
Revenue Growth
+96.92%
P/S Ratio
17.66
Revenue / Employee
7.79M
Employees
2
Market Cap
275.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.58M | 7.67M | 96.92% |
| Dec 31, 2024 | 7.91M | 934.00K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 118.21M |
| Aqua Bio Technology ASA | 101.51M |
| Arctic Bioscience AS | 45.90M |
| Oncoinvent ASA | 20.00M |
| PCI Biotech Holding ASA | 4.69M |
| Nykode Therapeutics AS | 4.57M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma AS | 377.00K |